News

New analyses from the landmark PROactive study examined the effects of Actos on the risk of stroke and other cardiovascular outcomes in high-risk patients with type 2 diabetes,

Celacade was also shown to be safe and well tolerated in the trial, which was named ACCLAIM. The results were presented at the World Congress of Cardiology 2006

The consideration of 1,200,000 shares of China Biopharmaceuticals common stock and the additional capital contribution of $620,000 will be returned to China Biopharmaceuticlas and the company will have

The court, however, did not order Apotex to recall products already sold or shipped. Plavix is a therapeutic designed to help prevent strokes or heart attacks by keeping

Solx, a privately-held company developing new treatments for glaucoma, has developed its DeepLight system, which can be used to provide patients with multiple options for intraocular pressure reduction.

The company plans to ship approximately 50 million doses of the vaccine this year and is expected to supply approximately half of the global influenza vaccines market. As

The two generic drug manufacturers have been attempting to sell cheaper copies of Lovenox, a blood thinner, in the US. However, the patent does not expire until 2012.

Multaq is an investigational therapeutic for atrial flutters or fibrillations, a condition that affects approximately $2 million Americans. The application was made last year and Euroepan regulators are

The grant will support the development of the company’s anthrax immune globulin (AIG) therapeutic product. The company is developing its AIG product as a single dose intravenous therapeutic